AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Harmony Biosciences to Participate in 2025 Cantor Global Healthcare Conference: Fireside Chat Scheduled for September 4, 2025
ByAinvest
Thursday, Aug 21, 2025 8:08 am ET1min read
Harmony Biosciences will participate in the 2025 Cantor Global Healthcare Conference on September 4, 2025, with a fireside chat at 2:10 p.m. ET. The company will discuss its therapies for rare neurological diseases. The presentation will be webcast on the Harmony Biosciences investor page. Harmony Biosciences is a pharmaceutical company focused on developing innovative therapies for patients with rare neurological diseases.
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has announced that its management team will participate in a fireside chat at the 2025 Cantor Global Healthcare Conference in New York, New York, on Thursday, September 4, 2025, at 2:10 p.m. ET. The event is an opportunity for investors and healthcare professionals to engage with Harmony Biosciences' leadership and learn about the company's innovative therapies for rare neurological diseases.The fireside chat will be webcast on the Harmony Biosciences investor page, allowing attendees to access the discussion remotely. Harmony Biosciences, established by Paragon Biosciences, LLC, in 2017, is dedicated to developing and commercializing therapies for patients with rare neurological diseases who have unmet medical needs. The company's focus on novel science, visionary thinking, and a commitment to those who feel overlooked has driven its mission to create a better future for these patients.
For more information about Harmony Biosciences and its upcoming fireside chat, visit www.harmonybiosciences.com. The webcast will be available on the company's investor page at https://ir.harmonybiosciences.com/.
References:
[1] https://www.marketscreener.com/news/harmony-biosciences-to-participate-in-2025-cantor-global-healthcare-conference-ce7c51d3de8bf023
[2] https://www.stocktitan.net/news/HRMY/harmony-biosciences-to-participate-in-2025-cantor-global-healthcare-upixqwr9bebd.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet